Double trouble: IRAK1/4 inhibitors in AML/MDS

被引：0
|
作者：
Uckelmann, Hannah J. [1 ,2 ,3 ]
Klusmann, Jan-Henning [1 ,2 ,3 ]
机构：
[1] Goethe Univ Frankfurt, Frankfurt, Germany
[2] Frankfurt Canc Inst, Frankfurt, Germany
[3] German Canc Consortium, Dresden, Germany
来源：
BLOOD | 2023年 / 142卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：945 / 946
页数：2
相关论文
共 50 条
  • [21] Association of Polymorphisms in IRAK1, IRAK4 and MyD88, and Severe Invasive Pneumococcal Disease
    Carrasco-Colom, Jaume
    Jordan, Iolanda
    Alsina, Laia
    Garcia-Garcia, Juan-Jose
    Jose Cambra-Lasaosa, Francisco
    Anunciacion Martin-Mateos, Maria
    Juan, Manel
    Munoz-Almagro, Carmen
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (09) : 1008 - 1013
  • [22] Pacritinib Targets IRAK1 and Shows Synergy with HDAC and BET Inhibitors in Acute Myeloid Leukemia
    Puri, Alka
    Mahmood, Shawn
    Maertens, Bernadette
    Davare, Monika
    Kurtz, Stephen E.
    Tognon, Cristina E.
    Eden, Christopher O.
    Elferich, Johannes
    Shinde, Ujwal
    Druker, Brian J.
    Singer, Jack W.
    Agarwal, Anupriya
    BLOOD, 2016, 128 (22)
  • [23] Nonhematopoietic IRAK1 drives arthritis via chemoattractants
    Hoyler, Thomas
    Bannert, Bettina
    Andre, Cedric
    Beck, Damian
    Boulay, Thomas
    Buffet, David
    Caesar, Nadja
    Calzascia, Thomas
    Dawson, Janet
    Kyburz, Diego
    Hennze, Robert
    Huppertz, Christine
    Littlewood-Evans, Amanda
    Loetscher, Pius
    Mertz, Kirsten D.
    Niwa, Satoru
    Robert, Gautier
    Rush, James S.
    Ruzzante, Giulia
    Sarret, Sophie
    Stein, Thomas
    Touil, Ismahane
    Wieczorek, Grazyna
    Zipfel, Geraldine
    Hawtin, Stuart
    Junt, Tobias
    JCI INSIGHT, 2022, 7 (13)
  • [24] IRAK1, a potential therapeutic target for rheumatoid arthritis?
    Xie, Qiang
    Wang, Shi-Cun
    Li, Jun
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (12) : 3069 - 3070
  • [25] Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome
    Rhyasen, Garrett W.
    Bolanos, Lyndsey
    Fang, Jing
    Jerez, Andres
    Wunderlich, Mark
    Rigolino, Carmela
    Mathews, Lesley
    Ferrer, Marc
    Southall, Noel
    Guha, Rajarshi
    Keller, Jonathan
    Thomas, Craig
    Beverly, Levi J.
    Cortelezzi, Agostino
    Oliva, Esther N.
    Cuzzola, Maria
    Maciejewski, Jaroslaw P.
    Mulloy, James C.
    Starczynowski, Daniel T.
    CANCER CELL, 2013, 24 (01) : 90 - 104
  • [26] IRAK1, a potential therapeutic target for rheumatoid arthritis?
    Qiang Xie
    Shi-Cun Wang
    Jun Li
    Rheumatology International, 2013, 33 : 3069 - 3070
  • [27] Molecular characterization, expression and functional analysis of IRAK1 and, Cheek for IRAK4 in Nile tilapia (Oreochromis niloticus)
    Han, Xueqing
    Gao, Fengying
    Lu, Maixin
    Liu, Zhigang
    Wang, Miao
    Ke, Xiaoli
    Yi, Mengmeng
    Cao, Jianmeng
    FISH & SHELLFISH IMMUNOLOGY, 2020, 97 : 135 - 145
  • [28] IRAK1: A novel TOLLway to target ovarian cancer
    Standing, David
    Gunewardena, Sumedha
    Sayed, Afreen A.
    Pritchard, Michele T.
    Pathak, Harsh B.
    Godwin, Andrew K.
    Petersen, Shariska
    Khabele, Dineo
    Roy, Jensen A.
    Dandawate, Prasad
    Weir, Scott J.
    Anant, Shrikant
    CANCER RESEARCH, 2022, 82 (12)
  • [29] Recent Advances in IRAK1: Pharmacological and Therapeutic Aspects
    Kim, Kyeong Min
    Hwang, Na-Hee
    Hyun, Ja-Shil
    Shin, Dongyun
    MOLECULES, 2024, 29 (10):
  • [30] IRAK1: A critical signaling mediator of innate immunity
    Gottipati, Sridevi
    Rao, Navin L.
    Fung-Leung, Wai-Ping
    CELLULAR SIGNALLING, 2008, 20 (02) : 269 - 276
12345